PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis.
PerioTrap Pharmaceuticals GmbH has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
PerioTrap Pharmaceuticals GmbH's investors include bmp Ventures, Companisto, IBG Beteiligungsgesellschaft Sachsen-Anhalt, i&i Prague, Ferton Holding SA.
PerioTrap Pharmaceuticals GmbH is headquartered in Haale, Germany.
PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis.
PerioTrap Pharmaceuticals GmbH is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PerioTrap Pharmaceuticals GmbH — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/periotrap-pharmaceuticals-gmbh. Accessed September 14, 2026.
VCBacked. (2025). PerioTrap Pharmaceuticals GmbH — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/periotrap-pharmaceuticals-gmbh
{{cite web |title=PerioTrap Pharmaceuticals GmbH — Funding & Investors |url=https://www.vcbacked.co/company/periotrap-pharmaceuticals-gmbh |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated